| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/23/2008 | US7427471 Modified “S” antibodies |
| 09/23/2008 | US7427470 Antisense modulation of helicase-moi expression |
| 09/23/2008 | US7427469 Method of treating cytomegalovirus with DC-SIGN blockers |
| 09/23/2008 | US7427402 for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis; treatment to prevent such skin inflammatory disorders using antagonists of IL- 17A, IL-17F, IL-19, and/or IL-23 |
| 09/23/2008 | US7427399 Antibodies and related molecules that bind to 161P2F10B proteins |
| 09/23/2008 | US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis |
| 09/23/2008 | CA2445687C Compositions, methods and systems for the discovery of enediyne natural products |
| 09/23/2008 | CA2309838C Haptoglobin assay |
| 09/23/2008 | CA2290863C Plant transformation methods |
| 09/23/2008 | CA2264967C Method of dna sequencing |
| 09/23/2008 | CA2227281C Determination of an analyte in a liquid medium |
| 09/23/2008 | CA2226721C Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles |
| 09/23/2008 | CA2219106C Nucleic acid ligands of tissue target |
| 09/23/2008 | CA2195209C Use of rna polymerase to improve nucleic acid amplification process |
| 09/23/2008 | CA2169852C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 09/23/2008 | CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 09/18/2008 | WO2008113013A2 C-met mutations and uses thereof |
| 09/18/2008 | WO2008112990A2 Methods of diagnosis and treatment of crohn's disease |
| 09/18/2008 | WO2008112980A2 Method and system for assembly of macromolecules and nanostructures |
| 09/18/2008 | WO2008112903A2 Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes |
| 09/18/2008 | WO2008112898A2 Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes |
| 09/18/2008 | WO2008112891A2 Monoclonal antibody that recognizes a seneca valley virus (svv) cellular receptor and uses thereof |
| 09/18/2008 | WO2008112772A2 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | WO2008112703A2 Compositions and methods for diagnosing and treating diabetic micro vascular complications |
| 09/18/2008 | WO2008112683A2 Gene synthesis by circular assembly amplification |
| 09/18/2008 | WO2008112626A1 Non-linear rotation rates of remotely driven particles and uses thereof |
| 09/18/2008 | WO2008112311A1 Methods for identifying diabetes and obesity therapeutics |
| 09/18/2008 | WO2008112274A2 K-ras and b-raf mutations and anti-egfr antibody therapy |
| 09/18/2008 | WO2008112269A2 K-ras mutations and anti-egfr antibody therapy |
| 09/18/2008 | WO2008112195A1 Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| 09/18/2008 | WO2008112193A1 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents |
| 09/18/2008 | WO2008112177A2 Genemap of the human genes associated with schizophrenia |
| 09/18/2008 | WO2008112166A2 Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 09/18/2008 | WO2008112154A2 Methods of using genomic biomarkers to predict tumor formation |
| 09/18/2008 | WO2008112108A1 In vivo hcv resistance to anti-viral inhibitors |
| 09/18/2008 | WO2008112015A2 Compositions, kits, and methods for isolating cytoplasmic rna |
| 09/18/2008 | WO2008111981A1 Compositions, systems, and methods for preservation of macromolecules |
| 09/18/2008 | WO2008111818A1 Method and kit for detecting a target protein using a dna aptamer |
| 09/18/2008 | WO2008111741A1 Method for detecting nucleotide variations using labelled primers |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111527A1 Method of evaluating foam-holding property of fermented malt drink and marker for evaluating foam-holding |
| 09/18/2008 | WO2008111485A1 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 09/18/2008 | WO2008111453A1 Method for amplification of dna fragment |
| 09/18/2008 | WO2008111161A1 Method of identifying uniformity of mesenchymal stem cells and uniform mesenchymal stem cells isolated using the method |
| 09/18/2008 | WO2008111104A1 A diagnostic method for the determination of helicobacter pylori |
| 09/18/2008 | WO2008111083A2 Methods for diagnosis of maculopathies |
| 09/18/2008 | WO2008111063A2 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 09/18/2008 | WO2008111062A1 Methods of determining total pon1 level |
| 09/18/2008 | WO2008111047A1 Micro-nails for use in electrical interaction with cells |
| 09/18/2008 | WO2008110828A1 Method for prevention of age-related macular degeneration (amd) |
| 09/18/2008 | WO2008110824A2 Diagnostic test for age-related macular degeneration (amd) |
| 09/18/2008 | WO2008110803A1 Somatotransgenic bioimaging |
| 09/18/2008 | WO2008110784A1 Pathogenic protein |
| 09/18/2008 | WO2008110655A1 Method for the simultaneous detection and quantification of dna from wheat, barley, rye and crosses and mixtures thereof in food, elements required to perform same and use thereof |
| 09/18/2008 | WO2008110622A1 Method and test kit for the rapid detection of specific nucleic acid sequences, especially for detecting mutations or snps |
| 09/18/2008 | WO2008110375A1 Device and method for the online control of drinking water on human tolerance within a drinking water supply network |
| 09/18/2008 | WO2008110367A2 Method for the genomic typing of erythrocyte systems, oligonucleotide probes and relative diagnostic kits |
| 09/18/2008 | WO2008110206A1 Method for determining a hla-dq haplotype in a subject |
| 09/18/2008 | WO2008110006A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | WO2008109996A1 Assessing chemotherapy resistance of colorectal tumors by determining sparc hypermethylation |
| 09/18/2008 | WO2008109945A1 Analysis of ribonucleic acid |
| 09/18/2008 | WO2008090177A3 Diagnosis of prostate cancer |
| 09/18/2008 | WO2008088524A3 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 09/18/2008 | WO2008087419A3 Animal model for adhd |
| 09/18/2008 | WO2008086381A3 Isothermal dna amplification |
| 09/18/2008 | WO2008075977A3 Methods and compositions for the assessment of cardiovascular function and disorders |
| 09/18/2008 | WO2008070359A3 Methods for diagnosing chronic fatigue syndrome |
| 09/18/2008 | WO2008069889A9 Methods of treating hemolytic anemia |
| 09/18/2008 | WO2008063655A9 Dna methylation markers and methods of use |
| 09/18/2008 | WO2008063414A9 Gene expression profiling for identification, monitoring, and treatment of colorectal cancer |
| 09/18/2008 | WO2008060687A9 High-throughput methods for quantifying cells in environmental and laboratory samples |
| 09/18/2008 | WO2008059252A9 Methods and composition fro t cell receptors which recognize 5t4 antigen |
| 09/18/2008 | WO2008048673A3 Sequences diagnostic for shrimp pathogens |
| 09/18/2008 | WO2008045505A3 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| 09/18/2008 | WO2008039445A9 Polymorphisms in the human xbp-1 gene are associated with inflammatory bowel disease |
| 09/18/2008 | WO2008036970A3 Insulin-degrading enzyme mutants and methods of use |
| 09/18/2008 | WO2008002740A3 Methods, compositions, and kits for rna extraction |
| 09/18/2008 | WO2007109183A3 Mutations and polymorphisms of fms-related tyrosine kinase 1 |
| 09/18/2008 | WO2007106509A3 Methods and means for nucleic acid sequencing |
| 09/18/2008 | WO2007079284A3 Lung cancer diagnostic assay |
| 09/18/2008 | WO2007067719A3 Diagnosing human diseases by detecting dna methylation changes |
| 09/18/2008 | US20080229446 Expression vector comprising nucleotide sequences coding isomerase for use in generating plants with enhanced isoprenoid biosynthesis |
| 09/18/2008 | US20080229442 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
| 09/18/2008 | US20080229441 Fungal endophytes of elymus canadensis |
| 09/18/2008 | US20080229440 Cucumber line apd147-5002gy |
| 09/18/2008 | US20080229436 Methods for identifying modulators of lifespan and resistance to oxidative stress |
| 09/18/2008 | US20080229435 Using mitogen activated kinase as tool in identifying modulators for treatment and prevention of cell proliferative disorders |
| 09/18/2008 | US20080228589 Methods For Placing, Accepting, And Filling Orders For Products and Services |
| 09/18/2008 | US20080228054 Analyte measuring device |
| 09/18/2008 | US20080228051 Analyte measuring device |
| 09/18/2008 | US20080227955 Nematode PAN and ZP Receptor-Like Sequences |
| 09/18/2008 | US20080227848 Identifying agent which modulates 2-oxoglutarate dependent oxygenase; ankyrin substrate; hypoxia-inducible factor; thalassemia |
| 09/18/2008 | US20080227844 evaluating bucindolol treatment for patient with heart failure; whether to administer bucindolol based on if the patient is homozygous for the Arg 389 polymorphism in the .beta.1-adrenergic receptor; bucindolol not indicated wherein the patient is a Del322-325 carrier in alpha2cAR; pharmacogenetics |
| 09/18/2008 | US20080227819 Method for identifying the agonistic activity of a target compound on a potassium channel |
| 09/18/2008 | US20080227754 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/18/2008 | US20080227750 Complex of glycan and galactin accumulated on cell surfaces; therapy, prevention of autoimmune diseases |
| 09/18/2008 | US20080227742 Photocleavable oligonucleotide and uses thereof |
| 09/18/2008 | US20080227741 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227738 Compositions and methods for cell dedifferentiation and tissue regeneration |